Intranasal Vaccination with Chitosan-DNA Nanoparticles Expressing Pneumococcal Surface Antigen A Protects Mice against Nasopharyngeal Colonization byStreptococcus pneumoniae

Protection against Pneumococcal Colonization and Fatal Pneumonia by a Trivalent Conjugate of a Fusion Protein with the Cell Wall Polysaccharide

(2009) Y.-J. Lu et al.   INFECTION AND IMMUNITY

Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice

(2009) Zhe Zhang et al.   JOURNAL OF CLINICAL INVESTIGATION

Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: Potential implications for pneumococcal conjugate vaccines

(2009) Gail L. Rodgers et al.   VACCINE

Optimized Immune Response Elicited by a DNA Vaccine Expressing Pneumococcal Surface Protein A Is Characterized by a Balanced Immunoglobulin G1 (IgG1)/IgG2a Ratio and Proinflammatory Cytokine Production

(2008) D. M. Ferreira et al.   Clinical and Vaccine Immunology

Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens

(2008) Meredith M. Curtis et al.   IMMUNOLOGY

Nucleic acid delivery with chitosan and its derivatives

(2008) Wing-Fu Lai et al.   JOURNAL OF CONTROLLED RELEASE

The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease

(2008) Aras Kadioglu et al.   NATURE REVIEWS MICROBIOLOGY

Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus

(2008) Xiao Wang et al.   VACCINE

Intranasal immunization with chitosan/pCETP nanoparticles inhibits atherosclerosis in a rabbit model of atherosclerosis

(2008) Xiying Yuan et al.   VACCINE

Streptococcus pneumoniae diseases in Chinese children: Past, present and future

(2008) Kai-hu Yao et al.   VACCINE

Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization

(2008) Ying-Jie Lu et al.   PLoS Pathogens